Bioorganic and Medicinal Chemistry Letters p. 2586 - 2590 (2010)
Update date:2022-08-05
Topics:
Bursavich, Matthew G.
Brooijmans, Natasja
Feldberg, Lawrence
Hollander, Irwin
Kim, Stephen
Lombardi, Sabrina
Park, Kaapjoo
Mallon, Robert
Gilbert, Adam M.
A series of benzofuran-3-one indole phosphatidylinositol-3-kinases (PI3K) inhibitors identified via HTS has been prepared. The optimized inhibitors possess single digit nanomolar activity against p110α (PI3K-α), good pharmaceutical properties, selectivity versus p110γ (PI3K-γ), and tunable selectivity versus the mammalian target of rapamycin (mTOR). Modeling of compounds 9 and 32 in homology models of PI3K-α and mTOR supports the proposed rationale for selectivity. Compounds show activity in multiple cellular proliferation assays with signaling through the PI3K pathway confirmed via phospho-Akt inhibition in PC-3 cells.
View MoreNanJing Rate Biochemicals CO., LTD
Contact:+86-25-84931986
Address:NO. 1 Hongjing Road,Jiangning Science Park,Nanjing,China
Compro Shijiazhuang Fine Chemical Co., Ltd
Contact:0086-311-89689838
Address:Economic and Technological Development Zone of Shijiazhuang,Hebei
Contact:+49-9398-993127
Address:Untertorstr. 27
Huangshan Violet Biological Technology Co., Ltd
Contact:+86-559-2335676
Address:16-201 JinShanYuan,JiangNan New City,TunXi District,HuangShan City,AnHui Province,China
Shanghai Yudiao Chemistry Technology Co.,Ltd
Contact:0086-18964703211
Address:Building NO.5, NO.218,Rongtian Road,ganxiang town,Jinshan District,shanghai,201518,china
Doi:10.1016/j.tetlet.2009.09.108
(2009)Doi:10.1007/BF00869032
()Doi:10.1021/jm00295a028
(1970)Doi:10.1039/J29710001142
(1971)Doi:10.1023/B:RUCO.0000047465.70746.fd
(2004)Doi:10.1002/1522-2675(20010131)84:1<163::AID-HLCA163>3.0.CO;2-B
(2001)